ARCUTIS BIOTHERAPEUTICS INC
ARCUTIS BIOTHERAPEUTICS INC logo
ARQT

ARCUTIS BIOTHERAPEUTICS INC (ARQT)

$17.190.76%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$16.51
Day's Range
$17.33
$13.59
52-Week Range
$27.4
1 month return3.51%
3 month return33.9%
1 year return2.96%
5 year return21.74%

Company Information

Arcutis Biotherapeutics, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. Arcutis' robust pipeline includes four novel drug candidates currently in development for a range of inflammatory dermatological conditions. The company's lead product candidate, topical roflumilast, has the potential to become the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis.
OrganizationARCUTIS BIOTHERAPEUTICS INC
Employees147
CEOMr. Todd Franklin Watanabe M.A.
IndustryHealth Technology

Analyst Recommendation

based on 6 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 6 Wall street analysts offering stock ratings for ARCUTIS BIOTHERAPEUTICS INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 220.59%

Current

$17.19

Target

$55.11

Recommendation Trend

Based on 6 analyst

Current1M Ago3M Ago
Buy
6
14
12
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
1.1B
Book Value
$4.45
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-4.67
Wall Street Target Price
55.11

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
4.04
Enterprise Value
819.6M
Enterprise Value/Revenue
1130.46
Enterprise Value/Ebitda
-2.72

Technicals

Beta
0.44
50 Day MA
18.43
200 Day MA
20.17

Institutional Holdings

FMR Inc

12.66%

Orbimed Advisors, LLC

7.85%

Bain Capital Life Sciences Investors, LLC

4.93%

State Street Corporation

4.36%

Vanguard Group Inc

3.7%

Point72 Asset Management, L.P.

3.26%

Discover more

Frequently Asked Questions

What is ARCUTIS BIOTHERAPEUTICS INC share price today?

Can Indians buy ARCUTIS BIOTHERAPEUTICS INC shares?

How can I buy ARCUTIS BIOTHERAPEUTICS INC shares from India?

Can Fractional shares of ARCUTIS BIOTHERAPEUTICS INC be purchased?

What are the documents required to start investing in ARCUTIS BIOTHERAPEUTICS INC stocks?

What are today’s High and Low prices of ARCUTIS BIOTHERAPEUTICS INC?

What are today’s traded volumes of ARCUTIS BIOTHERAPEUTICS INC?

What is today’s market capitalisation of ARCUTIS BIOTHERAPEUTICS INC?

What is the 52 Week High and Low Range of ARCUTIS BIOTHERAPEUTICS INC?

How much percentage ARCUTIS BIOTHERAPEUTICS INC is down from its 52 Week High?

How much percentage ARCUTIS BIOTHERAPEUTICS INC is up from its 52 Week low?

What are the historical returns of ARCUTIS BIOTHERAPEUTICS INC?

Who is the Chief Executive Officer (CEO) of ARCUTIS BIOTHERAPEUTICS INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*